BMLL — Bio Medica Laboratories Balance Sheet
0.000.00%
- IN₹1.88bn
- IN₹2.28bn
- IN₹430.90m
Annual balance sheet for Bio Medica Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PRESS |
| Standards: | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Preliminary |
| Cash | ||||
| Cash and Equivalents | ||||
| Cash and Short Term Investments | 0.061 | 0.103 | 0.068 | 1.03 |
| Net Total Accounts Receivable | ||||
| Net Total Receivables | 49.8 | 30.5 | 128 | 159 |
| Total Inventory | ||||
| Prepaid Expenses | ||||
| Total Other Current Assets | ||||
| Total Current Assets | 91 | 106 | 311 | 547 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | 83.1 | 87.3 | 74.6 | 105 |
| Net Intangible Assets | ||||
| Long Term Notes Receivable | ||||
| Other Long Term Assets | ||||
| Total Assets | 176 | 195 | 391 | 733 |
| Accounts Payable | ||||
| Notes Payable / Short Term Debt | ||||
| Current Portion of Long Term Debt / Capital Leases | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 102 | 65.6 | 170 | 192 |
| Long Term Debt | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Minority Interest | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 151 | 146 | 244 | 468 |
| Common Stock | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Total Equity | 24.4 | 49.4 | 147 | 265 |
| Total Liabilities & Shareholders' Equity | 176 | 195 | 391 | 733 |
| Total Common Shares Outstanding |